Non-TBI conditioning achieves positive results in MRD-negative CAYA B-ALL undergoing allogeneic HCT

Independent clones in CLL show oligoclonality and early evolution patterns

Isatuximab with VRd can benefit newly diagnosed multiple myeloma transplant ineligible patients

Understanding pharmacovigilance in Kenya

Analysis of dexamethasone-enhanced pre-medication in motixafortide-induced haematopoietic stem cell mobilisation for MM

Choosing 1st line TKI Wisely in patients with CML

Faecal microbiota transplantation increases activity of immunotherapy in mRCC

Status of anti BCMA therapy in myeloma

Addressing the rise of multiple myeloma in Rwanda

Isatuximab shows benefit in transplant-ineligible patients with newly diagnosed multiple myeloma

Manageable safety profile with early efficacy of Tec-DR in NDMM

Treatment of multiple myeloma in Turkey